Skip to main content
Premium Trial:

Request an Annual Quote

IBM, Accelrys Participate in Grid Project for Smallpox Research

NEW YORK, Feb. 6 - IBM and Accelrys have partnered with United Devices to provide informatics technologies for a project that will use use grid technology to uncover treatments for smallpox.


The effort is similar to the [email protected] project, in which idle personal computers are linked so that their dormant processors can be combined to work on the problem.


IBM will provide the infrastructure with its eServer p690s. Meantime, IBM's DB2 software, which the p690s will run, will handle 15 million SQL queries per day from about 2 million PCs. Accelrys is providing life-sciences software. United Devices, a grid computing company, is coordinating the project.


Results from the collaboration, called the Smallpox Research Grid Project, will be delivered to the US Department of Defense. Individuals can participate by visiting  


Additional participants include: Evotec, which has provided its drug modeling expertise to identify and define active sites; the University of Oxford, assisted by researchers at Essex University and the Robarts Research Institute, has prepared the targets that will used with Accelrys' LigandFit, and has contributed its large molecular library to the project; and the United States Army Medical Research Institute of Infectious Diseases.


Click here for more information.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.